We are live on ! Find out more
HSCS icon

Heart Test Laboratories

19 hedge funds and large institutions have $203K invested in Heart Test Laboratories in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

90% more funds holding

Funds holding: 1019 (+9)

0.03% less ownership

Funds ownership: 0.05%0.02% (-0.03%)

12% less capital invested

Capital invested by funds: $232K → $203K (-$28.9K)

Holders
19
Holders Change
+9
Holders Change %
+90%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

HSCS Hedge Fund Activity: Q4 2023 in Review

19 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2023, worth a combined $203K — down 12% from $232K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new HSCS positions and 1 closed out — a net gain of 9 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, adding an estimated $56.6K. The largest seller was Chapin Davis, cutting an estimated $9.85K.

  • 19 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2023, up from 10 in Q3 2023.
  • Funds reported $203K of Heart Test Laboratories stock for Q4 2023, down 12% quarter-over-quarter.
  • 10 funds opened new Heart Test Laboratories positions in Q4 2023 and 1 closed out, a net change of +9 holders.
  • The largest Heart Test Laboratories buyer in Q4 2023 was Virtu Financial, an estimated $56.6K added.
  • The largest Heart Test Laboratories seller in Q4 2023 was Chapin Davis, an estimated $9.85K sold.

Based on aggregated 13F filings for Q4 2023.